{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:26:32Z","timestamp":1791311192802,"version":"4.3.1"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T00:00:00Z","timestamp":1483401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000147","name":"Canadian Breast Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-142353"],"award-info":[{"award-number":["MOP-142353"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0168669","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T16:16:52Z","timestamp":1483978612000},"page":"e0168669","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":157,"title":["Claudin-Low Breast Cancer; Clinical & Pathological Characteristics"],"prefix":"10.1371","volume":"12","author":[{"given":"Kay","family":"Dias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dvorkin-Gheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin M.","family":"Hallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hassell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.","family":"Pond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita L.","family":"Bane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,1,3]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/gb-2007-8-5-r76","article-title":"Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors","volume":"8","author":"JI Herschkowitz","year":"2007","journal-title":"Genome Biol"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/bcr2635","article-title":"Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer","volume":"12","author":"A Prat","year":"2010","journal-title":"Breast Cancer Res"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.molonc.2010.11.003","article-title":"Deconstructing the molecular portraits of breast cancer","volume":"5","author":"A Prat","year":"2011","journal-title":"Mol Oncol"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1158\/0008-5472.CAN-08-3441","article-title":"Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics","volume":"69","author":"BT Hennessy","year":"2009","journal-title":"Cancer Res"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-13-228","article-title":"Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization","volume":"13","author":"R Sabatier","year":"2014","journal-title":"Mol Cancer"},{"issue":"29","key":"ref6","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1038\/sj.onc.1208561","article-title":"Identification of molecular apocrine breast tumours by microarray analysis","volume":"24","author":"P Farmer","year":"2005","journal-title":"Oncogene"},{"issue":"6797","key":"ref7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"CM Perou","year":"2000","journal-title":"Nature"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"e103514","DOI":"10.1371\/journal.pone.0103514","article-title":"Identification of a novel luminal molecular subtype of breast cancer","volume":"9","author":"A Dvorkin-Gheva","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/biostatistics\/kxp059","article-title":"Frozen robust multiarray analysis (fRMA)","volume":"11","author":"MN McCall","year":"2010","journal-title":"Biostatistics"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"WE Johnson","year":"2007","journal-title":"Biostatistics"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/bioinformatics\/btg385","article-title":"Adjustment of systematic microarray data biases","volume":"20","author":"M Benito","year":"2004","journal-title":"Bioinformatics"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"JS Parker","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref13","article-title":"Bioinformatics and Computational Biology Solutions using R and Bioconductor","author":"GK Smyth","year":"2005"},{"key":"ref14","first-page":"1165","article-title":"The control of the false discovery rate in multiple testing under dependency","volume":"29","author":"YY,D. Benjamini","year":"2001","journal-title":"Annals of Statistics"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1073\/pnas.1018854108","article-title":"Subtype and pathway specific responses to anticancer compounds in breast cancer","volume":"109","author":"LM Heiser","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","article-title":"Tumor Factors Predictive of Response to Hypofractionated Radiotherapy in a Randomized Trial Following Breast Conserving Therapy","author":"AL Bane","year":"2014","journal-title":"Ann Oncol"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"TJ Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"ref18","unstructured":"Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, Van De Vijver MJ. WHO Classification of Tumours of the Breast.; 2012."},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up","volume":"19","author":"CW Elston","year":"1991","journal-title":"Histopathology"},{"issue":"2","key":"ref20","first-page":"155","article-title":"Prognostic and predictive factors in breast cancer by immunohistochemical analysis","volume":"11","author":"DC Allred","year":"1998","journal-title":"Mod Pathol"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer","volume":"17","author":"JM Harvey","year":"1999","journal-title":"J Clin Oncol"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/modpathol.3800229","article-title":"Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study","volume":"17","author":"SK Mohsin","year":"2004","journal-title":"Mod Pathol"},{"issue":"31","key":"ref23","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"31","author":"AC Wolff","year":"2013","journal-title":"J Clin Oncol"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp082","article-title":"Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer","volume":"101","author":"MC Cheang","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/modpathol.3800491","article-title":"TMA-Combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays","volume":"18","author":"CL Liu","year":"2005","journal-title":"Mod Pathol"},{"issue":"16","key":"ref26","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","article-title":"Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma","volume":"10","author":"TO Nielsen","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/bcr3035","article-title":"A clinically relevant gene signature in triple negative and basal-like breast cancer","volume":"13","author":"A Rody","year":"2011","journal-title":"Breast Cancer Res"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1172\/JCI71103","article-title":"Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer","volume":"124","author":"C Li","year":"2014","journal-title":"J Clin Invest"},{"issue":"35","key":"ref29","doi-asserted-by":"crossref","first-page":"15449","DOI":"10.1073\/pnas.1004900107","article-title":"Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes","volume":"107","author":"JH Taube","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"ref30","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1158\/0008-5472.CAN-10-4554","article-title":"TGFbeta\/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype","volume":"71","author":"MK Asiedu","year":"2011","journal-title":"Cancer Res"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"e1002723","DOI":"10.1371\/journal.pgen.1002723","article-title":"EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice","volume":"8","author":"AP Morel","year":"2012","journal-title":"PLoS Genet"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1158\/1078-0432.CCR-09-1630","article-title":"Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer","volume":"16","author":"E Charafe-Jauffret","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"7","key":"ref33","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"M Al-Hajj","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref34","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome","volume":"1","author":"C Ginestier","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10549-013-2591-1","article-title":"Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers","volume":"140","author":"A Bane","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10911-010-9173-1","article-title":"Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer","volume":"15","author":"CJ Creighton","year":"2010","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1073\/pnas.1018862108","article-title":"Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells","volume":"109","author":"JI Herschkowitz","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ncomms2039","article-title":"TGFbeta induces the formation of tumour-initiating cells in claudinlow breast cancer","volume":"3","author":"A Bruna","year":"2012","journal-title":"Nat Commun"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1158\/0008-5472.CAN-12-2962","article-title":"FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer","volume":"73","author":"BG Hollier","year":"2013","journal-title":"Cancer Res"},{"key":"ref40","article-title":"Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential","author":"J Knezevic","year":"2015","journal-title":"Oncogene"},{"key":"ref41","article-title":"Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive and Triple-Negative Primary Breast Cancers","author":"C Denkert","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref42","article-title":"Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial","author":"S Loi","year":"2014","journal-title":"Ann Oncol"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1200\/JCO.2009.23.7370","article-title":"Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer","volume":"28","author":"C Denkert","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref44","article-title":"Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199","author":"S Adams","year":"2014","journal-title":"J Clin Oncol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0168669","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T05:33:50Z","timestamp":1568698430000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0168669"}},"subtitle":[],"editor":[{"given":"Pei-Yi","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,3]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0168669","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,3]]}}}